… Hepatitis B or C. The panel recommends that etanercept could potentially be used in RA
patients with hepatitis C requiring RA treatment (Table 4). The panel also recommends not …

With the increase in the number of multinational and multicultural research projects, the need
to adapt health status measures for use in other than the source language has also grown …

Clinicians and researchers without a suitable health-related quality of life (HRQOL) measure
in their own language have two choices: (1) to develop a new measure, or (2) to modify a …

Objective. To standardize outcome measures in systemic lupus erythematosus (SLE). Three
indices were identified which could adequately describe outcome (disease activity, damage …

Background Each year, clinical upper gastrointestinal events occur in 2 to 4 percent of patients
who are taking nonselective nonsteroidal antiinflammatory drugs (NSAIDs). We assessed …

To develop criteria for the classification of fibromyalgia, we studied 558 consecutive patients:
293 patients with fibromyalgia and 265 control patients. Interviews and examinations were …

This paper describes the development of an evaluative outcome measure for patients with
upper extremity musculoskeletal conditions. The goal is to produce a brief, self‐administered …

Background The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs
(NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-…

… , Canada; Daniel Furst, MD: Virginia Mason Medical C’enter, Seattle, Washington; Charles
Goldsmith, PhD: … A Westergren erythrocyte sedimentation rate or a C-reactive protein level. …

… Those most frequently measured are the ESR and the C-reactive protein (CRP) level.
Although the response of the ESR to different therapies is thought to be inconsistent, it is very …